VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 65 filers reported holding VERRICA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $115,766 | +115.0% | 19,555 | +41.1% | 0.00% | – |
| Q3 2023 | $53,834 | -56.8% | 13,857 | -35.8% | 0.00% | – |
| Q2 2023 | $124,603 | -72.7% | 21,595 | -69.2% | 0.00% | – |
| Q1 2023 | $456,073 | +894160.8% | 70,165 | +298.8% | 0.00% | – |
| Q3 2022 | $51 | -16.4% | 17,594 | -44.6% | 0.00% | – |
| Q2 2022 | $61 | -99.9% | 31,750 | +193.9% | 0.00% | – |
| Q1 2022 | $88,000 | -83.4% | 10,802 | -67.7% | 0.00% | – |
| Q4 2019 | $531,000 | +42.4% | 33,393 | +32.2% | 0.00% | – |
| Q3 2019 | $373,000 | -62.7% | 25,254 | -50.2% | 0.00% | – |
| Q2 2018 | $1,001,000 | – | 50,714 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 62,882 | $512,000 | 1.42% |
| Diag Capital Management, LP | 114,947 | $937,000 | 1.07% |
| Perceptive Advisors | 3,410,412 | $27,794,000 | 1.06% |
| Fosun International Ltd | 794,279 | $6,473,000 | 0.39% |
| Orbimed Advisors | 1,479,733 | $12,060,000 | 0.22% |
| PURA VIDA INVESTMENTS, LLC | 63,916 | $521,000 | 0.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 97,000 | $791,000 | 0.09% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 327,420 | $2,668,000 | 0.05% |
| Capital Investment Advisory Services, LLC | 12,400 | $101,000 | 0.04% |
| CONNING INC. | 129,013 | $1,051,000 | 0.04% |